Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15017 total
VSTS enters July with an unusual tension: the stock is up 10% on the week to $14.52, yet short sellers quietly added to positions over the same period. That rebuilding of short conviction is the week's most interesting…
BIRK enters July in an unusual split: short sellers have been covering aggressively, yet the borrow market has tightened to near-zero and options traders are the most defensively positioned they have been in…
Lithium Americas Corp. enters July with a striking internal contradiction: the stock is down 7% on the week and 24% over the past month, yet the borrow market has suddenly tightened after weeks of relative ease. The…
IBIT enters July with short sellers materially more aggressive than a month ago, even as the broader borrow market remains wide open — a divergence that makes the recent positioning shift worth watching closely. The…
BTQ Technologies heads into July with a striking disconnect: borrow costs have more than doubled in a month while short interest itself remains negligible, pointing to something more structural happening in the lending…
Intuitive Machines enters July with a striking split between what insiders are doing and what the Street is saying — and the short book is quietly catching up with both. The most conspicuous signal this week is insider…
GRND enters July with its most constructive analyst backdrop in months, after a bellwether upgrade landed just as the stock wrapped up a 9% weekly gain. The catalyst is fresh. Morgan Stanley's Nathan Feather upgraded…
FirstSun Capital Bancorp enters July with a fresh analyst upgrade on one side of the ledger and a meaningful week-on-week jump in short interest on the other — an unusual pairing for a stock that just logged a 4.7%…
Symbotic closed the week at $44.95, up 17% in five sessions — yet short interest climbed in near-lockstep, rising 10.5% over the same period to 14.5% of the free float. That tension between price and positioning is the…
QuidelOrtho has staged a striking 47% recovery over the past month — yet short sellers are not retreating, the Street's price targets sit well below the current price, and the next earnings test is less than four weeks…
FTAI Infrastructure enters July with a rare divergence: the stock just posted its best single-day gain in weeks, yet the options market has simultaneously flipped to its most defensive posture on record. The options…
Haleon heads into its July 30 results with a tidy 4.2% weekly gain and an almost complete absence of short-side pressure — a combination that leaves the setup looking calm rather than charged. The lending market tells…
Warner Bros. Discovery enters July with a fresh upgrade from Seaport Global cutting against an unrelenting wave of insider selling — the tension between those two signals defines the stock right now. The most notable…
NRGV enters July with short sellers building aggressively and the borrow market tightening at a pace that has few recent parallels — a combination that makes the stock's 11% weekly rally all the more striking. The…
MoonLake Immunotherapeutics ends the week in retreat — down 8.2% to $19.47 — with insiders still distributing stock and the extreme options bullishness flagged last week having quietly unwound. The insider selling is…
Apollo Global Management closes the week in a curious position: the stock is down 9.4% over five days yet options traders have swung decisively back toward calls, creating one of the more contradictory setups the name…
TeraWulf ends the week in an unusual place: down 14% while the analyst community is busier than ever adding buy ratings. The week's sharpest signal came from options markets. Defensive positioning has jumped to its…
Planet Labs PBC heads into its July 9 earnings report with options positioning at an extreme not seen all year, even as short sellers quietly cover into a 16% weekly rally. The most striking signal this week is in the…
Dave Inc. enters July with a sharp tension at its core: short interest has nearly doubled over the past month, yet the stock just rallied 17% in a single week, leaving a crowded bear trade nursing fresh losses. The…
Enliven Therapeutics heads into July with analyst conviction rising sharply on one side and a quiet but steady rebuild in short positioning on the other — a split that makes the setup more charged than the stock's…
